Education
About Us
Working with TipRanks
Follow Us
Owens & Minor (OMI)
NYSE:OMI
OMI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.07 - $25.85
Previous CloseN/A
Volume124.16K
Average Volume (3M)1.74M
Market Cap
$533.06M
Enterprise Value$3.19B
Total Cash (Recent Filing)$146.36M
Total Debt (Recent Filing)$208.15M
Price to Earnings (P/E)―
Beta0.87
Next Earnings
May 02, 2025EPS Estimate
0.2Last Dividend Ex-Date
Dec 14, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)-4.71
Shares Outstanding77,254,510
10 Day Avg. Volume2,070,340
30 Day Avg. Volume1,740,136
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.06
Price to Cash Flow (P/CF)2.50
P/FCF Ratio4.90
Enterprise Value/Market Cap5.98
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit153.82K
Enterprise Value/Ebitda43.81
Forecast
1Y Price Target
$10.72Price Target Upside55.36% Upside
Rating ConsensusHold
Number of Analyst Covering5
---
Owens & Minor News
PremiumCompany Announcements
Owens & Minor Announces $1 Billion Notes Offering
PremiumCompany Announcements
Owens & Minor Announces $600M Senior Notes Offering
PremiumCompany Announcements
Owens & Minor to Acquire Rotech Healthcare for $1.36B
PremiumCompany Announcements
Owens & Minor Faces Regulatory Hurdles in U.S. Healthcare Investments---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceOMI reported adjusted EPS of $0.55, which was ahead of both internal estimates and Visible Alpha consensus.
Shareholder ValueThe company announced a $100MM stock repurchase program, which is often viewed as a positive move for shareholder value.
Strategic ShiftOMI's decision to evaluate selling its Products & Healthcare Services (P&HS) segment is a strategic pivot to focus more heavily on Patient Direct (PD), which is a faster-growing business with a higher margin structure.
Bears Say
Earnings GuidanceThe adjusted EBITDA guide is below expectations, which may be a concern for some investors.
Growth ChallengesThe patient eligibility backlog from the Change outage is seeming to take longer to clear, creating a near-term headwind weighing on growth for OMI's key high growth/high margin segment.
Market SentimentThe new price objective considers a lower valuation framework reflecting elevated execution risk.
---
Ownership Overview
2.56% Insiders
38.67% Mutual Funds
0.13% Other Institutional Investors
27.79% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OMI FAQ
What was Owens & Minor’s price range in the past 12 months?
Owens & Minor lowest stock price was $6.07 and its highest was $25.85 in the past 12 months.
What is Owens & Minor’s market cap?
Owens & Minor’s market cap is $533.06M.
When is Owens & Minor’s upcoming earnings report date?
Owens & Minor’s upcoming earnings report date is May 02, 2025 which is in 18 days.
How were Owens & Minor’s earnings last quarter?
Owens & Minor released its earnings results on Feb 28, 2025. The company reported $0.55 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.03.
Is Owens & Minor overvalued?
According to Wall Street analysts Owens & Minor’s price is currently Undervalued.
Does Owens & Minor pay dividends?
Owens & Minor pays a Quarterly dividend of $0.002 which represents an annual dividend yield of N/A. See more information on Owens & Minor dividends here
What is Owens & Minor’s EPS estimate?
Owens & Minor’s EPS estimate is 0.2.
How many shares outstanding does Owens & Minor have?
Owens & Minor has 77,254,510 shares outstanding.
What happened to Owens & Minor’s price movement after its last earnings report?
Owens & Minor reported an EPS of $0.55 in its last earnings report, beating expectations of $0.52. Following the earnings report the stock price went up 39.042%.
Which hedge fund is a major shareholder of Owens & Minor?
Currently, no hedge funds are holding shares in OMI
---
Owens & Minor Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$10.72 (55.36% Upside)
$10.72 (55.36% Upside)
Blogger Sentiment
Bullish
OMI Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 15.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $34.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.6%
Last 30 Days ▼ 15.3%
Last 30 Days ▼ 15.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-73.40%
12-Months-Change
Fundamentals
Return on Equity
-48.70%
Trailing 12-Months
Asset Growth
-8.58%
Trailing 12-Months
Company Description
Owens & Minor
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.
---
OMI Company Deck
---
OMI Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call revealed several positive developments, including debt reduction, growth in the Patient Direct segment, and a new share repurchase program. However, there were notable challenges such as the impact of IV fluid shortages, a significant goodwill impairment charge, increased expenses, and flat gross margins. Although there are positive long-term prospects, immediate challenges balance the sentiment.Read More>---
OMI Stock 12 Month Forecast
Average Price Target
$10.72
▲(55.36% Upside)
Technical Analysis
Best Analysts Covering OMI
1 Year
1 Year Success Rate
9/11 ratings generated profit
1 Year Average Return
+17.40%
reiterated a sell rating last month
Copying Lisa Gill's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +17.40% per trade.
---